The National Trust for Scotland Arran Ranger Service is urging the public to be more careful as they revealed the impact fires have had on wildlife at Glen Rosa on the island. Adders, slow worms ...

For years, conservationists have been working to bring native trees back to the spectacular Glen Rosa on the Isle of Arran. But a decade of effort was wiped out in days when a wildfire ripped ...

A late night search was launched off the coast of Arran after a kayak was spotted floating in the Firth of Clyde. Arran Coastguard Rescue Team and volunteers from the RNLI were called out to the ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions. By the end of ...

Users can mash up two different images in the new Firefly Boards, creating a hybrid prompt to generate something new. In Photoshop, Adobe is adding Composition Reference, a tool we’ve seen ...

The models for MASH, UC, wound healing, and psoriasis have been meticulously developed and validated to closely mimic human disease, offering unparalleled insights into the underlying mechanisms ...

Agustín Ramírez had never taken a single at-bat at the big-league level prior to this week, but you wouldn’t be able to tell from looking at the box scores. The Miami Marlins called up the ...

"We're pleased to announce the dosing of first patient in our phase 2 study of DR10624 for the treatment of MASLD/MASH. Patients with MASLD face an increased risk of cardiovascular disease and type 2 ...

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH ...

MELAKA: The Tun Fatimah Form Six College in Durian Daun here has made history as the first school in Malaysia to be selected by the Asean Foundation for its artificial intelligence (AI ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...